EZH2 and Hepatic fibrosis: Thirdly, there might exist other genes also critical for anti‐fibrosis, and these genes were transrepressed by EZH2, in this sense, EPZ‐6438 administration might result in transactivation of these anti‐fibrotic genes, and therefore alleviating liver fibrosis (the unknown way).